Found: 4
Select item for more details and to access through your institution.
Leukocyte-associated immunoglobulin-like receptor-1 blockade in combination with programmed death-ligand 1 targeting therapy mediates increased tumour control in mice.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 1, p. 1, doi. 10.1007/s00262-023-03600-6
- By:
- Publication type:
- Article
Cancer immunotherapy by NC410, a LAIR-2 Fc protein blocking human LAIR- collagen interaction.
- Published in:
- eLife, 2021, p. 1, doi. 10.7554/eLife.62927
- By:
- Publication type:
- Article
A novel bioinformatics pipeline for the identification of immune inhibitory receptors as potential therapeutic targets.
- Published in:
- eLife, 2024, p. 1, doi. 10.7554/eLife.92870
- By:
- Publication type:
- Article
Collagen Fragments Produced in Cancer Mediate T Cell Suppression Through Leukocyte-Associated Immunoglobulin-Like Receptor 1.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.733561
- By:
- Publication type:
- Article